1. Home
  2. VSTS vs AGIO Comparison

VSTS vs AGIO Comparison

Compare VSTS & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTS
  • AGIO
  • Stock Information
  • Founded
  • VSTS 1936
  • AGIO 2007
  • Country
  • VSTS United States
  • AGIO United States
  • Employees
  • VSTS N/A
  • AGIO N/A
  • Industry
  • VSTS
  • AGIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • VSTS
  • AGIO Health Care
  • Exchange
  • VSTS Nasdaq
  • AGIO Nasdaq
  • Market Cap
  • VSTS 1.8B
  • AGIO 2.0B
  • IPO Year
  • VSTS N/A
  • AGIO 2013
  • Fundamental
  • Price
  • VSTS $13.05
  • AGIO $35.22
  • Analyst Decision
  • VSTS Hold
  • AGIO Buy
  • Analyst Count
  • VSTS 5
  • AGIO 7
  • Target Price
  • VSTS $14.08
  • AGIO $56.33
  • AVG Volume (30 Days)
  • VSTS 1.4M
  • AGIO 642.8K
  • Earning Date
  • VSTS 01-31-2025
  • AGIO 02-13-2025
  • Dividend Yield
  • VSTS 1.07%
  • AGIO N/A
  • EPS Growth
  • VSTS N/A
  • AGIO N/A
  • EPS
  • VSTS 0.07
  • AGIO 11.64
  • Revenue
  • VSTS $2,771,677,000.00
  • AGIO $36,498,000.00
  • Revenue This Year
  • VSTS $2.72
  • AGIO $166.22
  • Revenue Next Year
  • VSTS N/A
  • AGIO $98.36
  • P/E Ratio
  • VSTS $179.90
  • AGIO $3.03
  • Revenue Growth
  • VSTS N/A
  • AGIO 36.07
  • 52 Week Low
  • VSTS $8.92
  • AGIO $27.14
  • 52 Week High
  • VSTS $19.97
  • AGIO $62.58
  • Technical
  • Relative Strength Index (RSI)
  • VSTS 22.93
  • AGIO 54.02
  • Support Level
  • VSTS $13.50
  • AGIO $33.25
  • Resistance Level
  • VSTS $13.76
  • AGIO $34.86
  • Average True Range (ATR)
  • VSTS 0.34
  • AGIO 1.33
  • MACD
  • VSTS -0.05
  • AGIO 0.37
  • Stochastic Oscillator
  • VSTS 10.74
  • AGIO 97.99

About VSTS Vestis Corporation

Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.

Share on Social Networks: